ClinicalTrials.gg
Not yet recruitingNCT07940491Updated Nov 16, 2026

The Proteome of Chronic Urticaria

An observational study in Chronic Urticaria, sponsored by Zealand University Hospital. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Zealand University Hospital · Observational

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
80
Ages
18 Years and older
Sex
All
01

Study summary

Chronic urticaria (CU) is a dermatological condition characterized by recurrent itchy wheals and/or angioedema persisting for more than six weeks. Despite affecting approximately 1% of the global population, the pathophysiological mechanisms underlying CU remain poorly understood, and current treatment options are limited. We will investigate the proteome of CU by analyzing skin biopsies from patients using mass spectrometry-based proteomics. This approach will enhance our understanding of CU at the molecular level, potentially leading to improved diagnostic tools and more effective targeted therapies, ultimately improving the quality of life for patients suffering from this debilitating condition.

02

Conditions studied

  • Chronic Urticaria

Keywords

  • chronic urticaria
  • proteomics
  • mass spectrometry
  • urticaria
  • skin diseases
  • immune system diseases
03

In context

Chronic Urticaria

197 studies on the registry are indexed under Chronic Urticaria; 48 are open to participants now.

This study's planned enrollment of 80 is below the median of 165 across 40 observational studies indexed under Chronic Urticaria.

Browse Chronic Urticaria studies →

Lead sponsor

Zealand University Hospital is the lead sponsor of 237 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients will be recruited from the Dept. of Dermatology and Allergy at Herlev and Gentofte Hospital, the Dept. of Dermatology at Zealand University Hospital, as well as through advertising in Denmark.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals diagnosed with chronic urticaria
  • Healthy volunteers

Exclusion criteria

Exclusion Criteria:

  • Individuals under 18 years of age
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with chronic urticaria

    Patients with chronic urticaria.

    Procedure: Punch biopsy

  • Healthy controls

    Age-, sex- and site-matched healthy controls.

    Procedure: Punch biopsy

Interventions

  • ProcedurePunch biopsy

    Skin punch biopsy.

06

What researchers measure

Primary outcomes

  1. Proteomic characterisation

    Description of proteomic signatures, as measured by mass spectrometry

    Time frame: Data collection and analysis between late 2026 and late 2029

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Fricke J, Avila G, Keller T, Weller K, Lau S, Maurer M, Zuberbier T, Keil T. Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis. Allergy. 2020 Feb;75(2):423-432. doi: 10.1111/all.14037. Epub 2019 Oct 11. PubMed 31494963 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared in compliance with Danish legislation and The Research Ethics Committee for Region Zealand (Den Videnskabsetiske Komité for Region Sjælland).

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2026; primary completion for Dec 2028, 24 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 16, 2026
StartEst.
Dec 2026
Primary completionEst.
Dec 2028
CompletionEst.
Dec 2029
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07940491
Collaborators
Novo Nordisk Foundation, LEO Foundation
Responsible party
Beatrice Dyring-Andersen (Dermatologist and Associate Professor, Clinical Proteomics and Dermatology, Zealand University Hospital) — Principal investigator
First posted
Nov 16, 2026
Start date
Dec 2026 (estimated)
Primary completion
Dec 2028 (estimated)
Completion
Dec 2029 (estimated)
Last update
Nov 16, 2026

Study contacts

Beatrice Dyring-Andersen, MD, PhD
Contact
bdyr@regionsjaelland.dk
+4546323200
Marianne Bengtson Løvendorf, MSc, PhD
Contact
mlove@regionsjaelland.dk
Beatrice Dyring-Andersen, MD, PhD
principal investigator · Zealand University Hospital
Marianne Bengtson Løvendorf, MSc, PhD
principal investigator · Zealand University Hospital
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion